In the second part of his Pharma Commerce video interview, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, ...

President Donald Trump is right that Americans pay too high a price for many pharmaceuticals. In a May 12 speech and signing ...

Testing drug compounds on ... explain why there is a 90% failure rate during clinical development. The low rate of success is one of the contributors to the high cost and the slow R&D process ...

President Donald Trump signed a new executive order Monday aimed at slashing the cost of prescription drugs in the United ...

Donald Trump's executive order aims to drastically cut US prescription drug prices, aligning them with the lowest prices in ...

With US President Donald Trump leaning towards implementing additional tariffs on the pharmaceutical sector, there is potential to disrupt drug development costs and drug prices, with any tariffs ...